Nanobiotix is trading at $27.00, up 9.67% in after-hours trading; no clear company-specific catalyst was identified.

  • The latest company release found was an October 1 CFO appointment, not a same-day catalyst.
  • The gain ran against the modestly lower major indexes provided; available evidence does not establish a broader-market explanation.
  • No after-hours volume or other activity details were available to confirm what is driving the move.